172 related articles for article (PubMed ID: 1683798)
1. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice.
Yeager AM; Shinn C; Pardoll DM
Blood; 1991 Dec; 78(12):3312-6. PubMed ID: 1683798
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cell transplantation in the twitcher mouse. The effects of pretransplant conditioning with graded doses of busulfan.
Yeager AM; Shinn C; Shinohara M; Pardoll DM
Transplantation; 1993 Jul; 56(1):185-90. PubMed ID: 8101401
[TBL] [Abstract][Full Text] [Related]
3. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
4. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
Tomita Y; Sachs DH; Sykes M
Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
[TBL] [Abstract][Full Text] [Related]
5. Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice.
Yeager AM; Shinn C; Farmer ER; Wingard JR; Yeager MJ
Bone Marrow Transplant; 1992 Mar; 9(3):199-204. PubMed ID: 1354995
[TBL] [Abstract][Full Text] [Related]
6. Long-term hemopoietic repopulation by Thy-1lo, Lin-, Ly6A/E+ cells.
Li CL; Johnson GR
Exp Hematol; 1992 Dec; 20(11):1309-15. PubMed ID: 1362957
[TBL] [Abstract][Full Text] [Related]
7. Proliferation kinetics of immune cells during early phase of bone marrow transplantation in mouse model based on chemotherapy conditioning.
Chen C; DA Z; Lu Y; Zhou J; Li X; Fu B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 May; 46(5):449-457. PubMed ID: 34148880
[TBL] [Abstract][Full Text] [Related]
8. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.
Lapidot T; Terenzi A; Singer TS; Salomon O; Reisner Y
Blood; 1989 May; 73(7):2025-32. PubMed ID: 2653469
[TBL] [Abstract][Full Text] [Related]
10. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
12. Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation.
Garcia-Perez L; van Roon L; Schilham MW; Lankester AC; Pike-Overzet K; Staal FJT
Cells; 2021 Apr; 10(5):. PubMed ID: 33946560
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell transplantation after administration of high-dose busulfan in murine globoid cell leukodystrophy (the twitcher mouse).
Yeager AM; Shinohara M; Shinn C
Pediatr Res; 1991 Mar; 29(3):302-5. PubMed ID: 2034480
[TBL] [Abstract][Full Text] [Related]
14. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313
[TBL] [Abstract][Full Text] [Related]
15. Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.
Shi C; Li Z; Sun Z; Pan L
Transplant Cell Ther; 2024 Apr; 30(4):398.e1-398.e10. PubMed ID: 38331194
[TBL] [Abstract][Full Text] [Related]
16. Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts.
Hsieh MM; Langemeijer S; Wynter A; Phang OA; Kang EM; Tisdale JF
Exp Hematol; 2007 Sep; 35(9):1415-20. PubMed ID: 17618036
[TBL] [Abstract][Full Text] [Related]
17. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.
Arber C; BitMansour A; Sparer TE; Higgins JP; Mocarski ES; Weissman IL; Shizuru JA; Brown JM
Blood; 2003 Jul; 102(2):421-8. PubMed ID: 12663447
[TBL] [Abstract][Full Text] [Related]
18. [Earlier hematopoietic reconstitution by mouse cord blood transplantation combined with bone marrow c-kit(+) hematopoietic progenitor cells].
Yuan YH; Li J; Yu YH; Shi J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):416-21. PubMed ID: 21518499
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
